The company, based in Houston, Texas, provides a research toolkit spanning mechanistic investigation, biomarker detection, animal modelling, and custom services to support scientists exploring diabetes and associated metabolic disorders.
Driven by the rising global prevalence of the condition, pre-clinical diabetes research requires reliable animal disease models and well-validated biological reagents. Cloud-Clone Corp. combines these well-characterized animal models with comprehensive metabolic-research reagents to deliver technical support for investigators worldwide.
The demand for such resources is underscored by the significant global health burden imposed by diabetes and its complications. By providing these integrated animal models, detection assays, and services, the firm aims to support pre-clinical diabetes translational studies.
- Insulin-secretory kinetics markers.
- Insulin-resistance-related adipokines: Adiponectin, leptin, resistin, and visfatin to evaluate peripheral insulin sensitivity.
- Signalling-pathway reagents: Antibodies targeting IRS and GLUT4 for PI3K-AKT mechanistic studies.
- Complication-associated analytes: AGEs/RAGE, renal-function markers, and lipid panels supporting nephropathy and macrovascular-complication research.
- Inflammation and oxidative-stress panels: TNF-α, IL-6, MCP-1, SOD, and MDA for profiling chronic inflammatory and oxidative damage.
Flexible custom services are also available to meet the specific requirements of metabolic-disease investigators.
The current focus on research resources coincides with the annual observance of World Diabetes Day, which occurs on November 14. The event’s blue-circle logo serves as a symbol of life, health, and global solidarity. Projections indicate that the number of people affected will keep increasing in the coming decades, further emphasizing the need for ongoing investigation into diabetes prevention, management, and complications.
Readers interested in the application of these research tools should consult with qualified clinical or laboratory professionals to determine the appropriate methodologies for their specific study designs. The information provided by Cloud-Clone Corp. is intended for research support and does not constitute medical advice.